Canada Life’s Axon Enterprise AXON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.7M Buy
51,058
+1,872
+4% +$973K 0.04% 346
2025
Q4
$27.9M Sell
49,186
-61,820
-56% -$38.4M 0.05% 301
2025
Q3
$79.5M Buy
111,006
+24,503
+28% +$18.6M 0.11% 162
2025
Q2
$71.7M Buy
86,503
+18,362
+27% +$12.5M 0.11% 170
2025
Q1
$35.9M Sell
68,141
-1,507
-2% -$882K 0.06% 279
2024
Q4
$41.3M Buy
69,648
+9,466
+16% +$5.15M 0.07% 246
2024
Q3
$24.1M Buy
60,182
+2,944
+5% +$1.01M 0.04% 371
2024
Q2
$16.9M Sell
57,238
-32,623
-36% -$9.74M 0.03% 433
2024
Q1
$28.1M Buy
89,861
+38,269
+74% +$10.6M 0.06% 315
2023
Q4
$13.3M Buy
51,592
+1,399
+3% +$315K 0.03% 484
2023
Q3
$9.99M Sell
50,193
-35,310
-41% -$6.94M 0.02% 520
2023
Q2
$16.8M Sell
85,503
-32,113
-27% -$6.65M 0.04% 411
2023
Q1
$26.5M Buy
117,616
+61,755
+111% +$12.3M 0.07% 291
2022
Q4
$9.28M Buy
55,861
+8,146
+17% +$1.29M 0.02% 542
2022
Q3
$5.52M Buy
47,715
+4,348
+10% +$493K 0.02% 645
2022
Q2
$4.04M Buy
43,367
+6,305
+17% +$667K 0.01% 784
2022
Q1
$5.25M Buy
37,062
+4,048
+12% +$555K 0.01% 744
2021
Q4
$5.18M Buy
33,014
+2,343
+8% +$393K 0.01% 740
2021
Q3
$5.41M Buy
30,671
+5,553
+22% +$1.01M 0.01% 707
2021
Q2
$4.44M Buy
25,118
+329
+1% +$48.4K 0.01% 752
2021
Q1
$3.53M Sell
24,789
-1,745
-7% -$272K 0.01% 819
2020
Q4
$3.25M Sell
26,534
-3,456
-12% -$396K 0.01% 910
2020
Q3
$2.72M Sell
29,990
-1,295
-4% -$113K 0.01% 922
2020
Q2
$3.07M Buy
31,285
+254
+0.8% +$20.5K 0.01% 872
2020
Q1
$2.19M Buy
31,031
+1,869
+6% +$140K 0.01% 903
2019
Q4
$2.12M Buy
+29,162
New +$1.85M ﹤0.01% 1099
2019
Q3
Sell
-78,813
Closed -$5.05M 1226
2019
Q2
$5.05M Buy
78,813
+852
+1% +$55.6K 0.01% 732
2019
Q1
$4.24M Buy
77,961
+1,266
+2% +$64.9K 0.01% 700
2018
Q4
$3.1M Buy
76,695
+4,498
+6% +$233K 0.01% 809
2018
Q3
$4.94M Sell
72,197
-1,596
-2% -$108K 0.01% 704
2018
Q2
$4.66M Buy
73,793
+5,034
+7% +$272K 0.01% 735
2018
Q1
$2.7M Sell
68,759
-91
-0.1% -$2.84K 0.01% 960
2017
Q4
$1.82M Sell
68,850
-2,200
-3% -$52.8K ﹤0.01% 1234
2017
Q3
$1.64M Sell
71,050
-4,910
-6% -$115K ﹤0.01% 1281
2017
Q2
$1.91M Buy
75,960
+2,300
+3% +$56.2K 0.01% 1182
2017
Q1
$1.68M Buy
73,660
+5,840
+9% +$143K ﹤0.01% 1248
2016
Q4
$1.64M Sell
67,820
-4,867
-7% -$120K ﹤0.01% 1213
2016
Q3
$2.08M Buy
72,687
+1,745
+2% +$48.5K 0.01% 1024
2016
Q2
$1.76M Buy
70,942
+62,799
+771% +$1.3M 0.01% 1094
2016
Q1
$160K Buy
8,143
+4,547
+126% +$78K ﹤0.01% 1453
2015
Q4
$62K Hold
3,596
﹤0.01% 2048
2015
Q3
$79K Hold
3,596
﹤0.01% 1860
2015
Q2
$119K Hold
3,596
﹤0.01% 1735
2015
Q1
$86K Hold
3,596
﹤0.01% 1882
2014
Q4
$95K Hold
3,596
﹤0.01% 1793
2014
Q3
$56K Hold
3,596
﹤0.01% 1990
2014
Q2
$48K Buy
+3,596
New +$53.5K ﹤0.01% 1964

Other funds holding AXON

Canada Life's AXON Position: Q1 2026 in Review

Canada Life increased its Axon Enterprise (AXON) stake by 3.8% in Q1 2026, buying an estimated $973K and bringing the position to 51,058 shares worth $21.7M. The position accounts for 0.04% of the portfolio, ranked #346.

Canada Life first reported a position in AXON in Q2 2014 and has held it in 47 quarters since. The position peaked at $79.5M in Q3 2025. 1,048 funds tracked by Wall St. Rank hold AXON as of Q1 2026.

  • Canada Life held 51,058 shares of Axon Enterprise worth $21.7M as of Q1 2026.
  • Canada Life bought 1,872 Axon Enterprise shares in Q1 2026, an estimated $973K.
  • Axon Enterprise made up 0.04% of Canada Life's portfolio in Q1 2026, its #346 holding.
  • Canada Life first reported a position in Axon Enterprise in Q2 2014 and has held it in 47 quarters since.
  • Canada Life's Axon Enterprise position peaked at $79.5M in Q3 2025.
  • 1,048 funds tracked by Wall St. Rank held Axon Enterprise as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.